These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 23159330)
41. Therapeutic value of prenatal rapamycin treatment in a mouse brain model of tuberous sclerosis complex. Anderl S; Freeland M; Kwiatkowski DJ; Goto J Hum Mol Genet; 2011 Dec; 20(23):4597-604. PubMed ID: 21890496 [TBL] [Abstract][Full Text] [Related]
42. Conservation of structural and functional elements of TSC1 and TSC2: a bioinformatic comparison across animal models. Serfontein J; Nisbet RE; Howe CJ; de Vries PJ Behav Genet; 2011 May; 41(3):349-56. PubMed ID: 21243421 [TBL] [Abstract][Full Text] [Related]
43. Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent. Jaeschke A; Hartkamp J; Saitoh M; Roworth W; Nobukuni T; Hodges A; Sampson J; Thomas G; Lamb R J Cell Biol; 2002 Oct; 159(2):217-24. PubMed ID: 12403809 [TBL] [Abstract][Full Text] [Related]
44. Neocortical hyperexcitability in a human case of tuberous sclerosis complex and mice lacking neuronal expression of TSC1. Wang Y; Greenwood JS; Calcagnotto ME; Kirsch HE; Barbaro NM; Baraban SC Ann Neurol; 2007 Feb; 61(2):139-52. PubMed ID: 17279540 [TBL] [Abstract][Full Text] [Related]
45. Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease. Astrinidis A; Henske EP Oncogene; 2005 Nov; 24(50):7475-81. PubMed ID: 16288294 [TBL] [Abstract][Full Text] [Related]
46. Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex. Zhang B; Zou J; Rensing NR; Yang M; Wong M Neurobiol Dis; 2015 Aug; 80():70-9. PubMed ID: 26003087 [TBL] [Abstract][Full Text] [Related]
47. Tuberous sclerosis complex: advances in diagnosis, genetics, and management. Schwartz RA; Fernández G; Kotulska K; Jóźwiak S J Am Acad Dermatol; 2007 Aug; 57(2):189-202. PubMed ID: 17637444 [TBL] [Abstract][Full Text] [Related]
51. Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex. Goto J; Talos DM; Klein P; Qin W; Chekaluk YI; Anderl S; Malinowska IA; Di Nardo A; Bronson RT; Chan JA; Vinters HV; Kernie SG; Jensen FE; Sahin M; Kwiatkowski DJ Proc Natl Acad Sci U S A; 2011 Nov; 108(45):E1070-9. PubMed ID: 22025691 [TBL] [Abstract][Full Text] [Related]
52. mTOR inhibitor reverses autistic-like social deficit behaviours in adult rats with both Tsc2 haploinsufficiency and developmental status epilepticus. Schneider M; de Vries PJ; Schönig K; Rößner V; Waltereit R Eur Arch Psychiatry Clin Neurosci; 2017 Aug; 267(5):455-463. PubMed ID: 27263037 [TBL] [Abstract][Full Text] [Related]
53. Video-EEG monitoring methods for characterizing rodent models of tuberous sclerosis and epilepsy. Rensing NR; Guo D; Wong M Methods Mol Biol; 2012; 821():373-91. PubMed ID: 22125079 [TBL] [Abstract][Full Text] [Related]
54. Early developmental electroencephalography abnormalities, neonatal seizures, and induced spasms in a mouse model of tuberous sclerosis complex. Rensing N; Johnson KJ; Foutz TJ; Friedman JL; Galindo R; Wong M Epilepsia; 2020 May; 61(5):879-891. PubMed ID: 32274803 [TBL] [Abstract][Full Text] [Related]
55. Hypothalamic orexin and mechanistic target of rapamycin activation mediate sleep dysfunction in a mouse model of tuberous sclerosis complex. Zhang B; Guo D; Han L; Rensing N; Satoh A; Wong M Neurobiol Dis; 2020 Feb; 134():104615. PubMed ID: 31605778 [TBL] [Abstract][Full Text] [Related]
56. From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis. Ehninger D; de Vries PJ; Silva AJ J Intellect Disabil Res; 2009 Oct; 53(10):838-51. PubMed ID: 19694899 [TBL] [Abstract][Full Text] [Related]
57. Rescue of impaired blood-brain barrier in tuberous sclerosis complex patient derived neurovascular unit. Brown JA; Faley SL; Judge M; Ward P; Ihrie RA; Carson R; Armstrong L; Sahin M; Wikswo JP; Ess KC; Neely MD J Neurodev Disord; 2024 May; 16(1):27. PubMed ID: 38783199 [TBL] [Abstract][Full Text] [Related]
58. Impaired social interactions and motor learning skills in tuberous sclerosis complex model mice expressing a dominant/negative form of tuberin. Chévere-Torres I; Maki JM; Santini E; Klann E Neurobiol Dis; 2012 Jan; 45(1):156-64. PubMed ID: 21827857 [TBL] [Abstract][Full Text] [Related]
59. Rapamycin and dexamethasone during pregnancy prevent tuberous sclerosis complex-associated cystic kidney disease. Nechama M; Makayes Y; Resnick E; Meir K; Volovelsky O JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32484794 [TBL] [Abstract][Full Text] [Related]
60. Synaptic plasticity and learning in animal models of tuberous sclerosis complex. Kirschstein T Neural Plast; 2012; 2012():279834. PubMed ID: 22848848 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]